Lassen J, Baron R
Sektion Neurologische Schmerzforschung und -therapie, Klinik für Neurologie, Christian-Albrechts-Universität zu Kiel, Arnold-Heller-Str. 3, Haus D, 24105, Kiel, Deutschland.
Z Rheumatol. 2021 Apr;80(3):226-233. doi: 10.1007/s00393-020-00950-9. Epub 2020 Dec 23.
Pain is a leading symptom in inflammatory rheumatic diseases. For a long time it has been assumed that this pain is of nociceptive origin; however, in about one fifth of all patients the pain remains despite successful anti-inflammatory treatment and is not typically described as nociceptive by those affected. Recent studies indicate that some patients with rheumatoid arthritis (RA) experience pain with a neuropathic pain component. The treatment of neuropathic pain with damage to the somatosensory system differs markedly from the treatment of nociceptive pain in which the pain processing system is intact. Thus, the recognition and, above all, the more precise differentiation of the pain symptoms of affected patients make a decisive contribution to a successful treatment. With the help of a few points in the history and a physical examination, the assumption of the diagnosis neuropathic pain can often be rejected or substantiated. Pain with a neuropathic component does not adequately respond to typical analgesics. Instead, the high efficacy of co-analgesics, such as anticonvulsants and antidepressants, has been repeatedly proven.
疼痛是炎性风湿性疾病的主要症状。长期以来,人们一直认为这种疼痛源于伤害性刺激;然而,在所有患者中,约有五分之一的患者尽管抗炎治疗成功,但疼痛依然存在,而且患者通常并不将其描述为伤害性疼痛。最近的研究表明,一些类风湿关节炎(RA)患者经历的疼痛带有神经性疼痛成分。躯体感觉系统受损的神经性疼痛的治疗与疼痛处理系统完好的伤害性疼痛的治疗明显不同。因此,识别并尤其重要的是更精确地区分受影响患者的疼痛症状,对成功治疗起着决定性作用。借助病史中的几个要点和体格检查,神经性疼痛的诊断假设往往可以被排除或得到证实。带有神经性成分的疼痛对典型镇痛药反应不佳。相反,辅助镇痛药(如抗惊厥药和抗抑郁药)的高效性已得到反复证实。